2121非凡

  • 6a3a3d916f2b9
    Cancel
    Date：2026-06
    /index.php?a=shows&catid=34&id=938

    SynapX has officially announced that it has raised $50 million in a new financing round. Over the past three months, the company’s cumulative fundraising has reached nearly RMB 1 billion. This round was led by leading investors including Jinqiu Capital, Xinlian Capital, and Huangpu River Capital, with participation from JAFCO Asia, Houxue Capital, HKTT, Panga Capital, while existing shareholders such as Linear Venture continued to increase their investment. In addition, a subsequent financing of RMB 500 million is already close to being secured. CEC Capital acted as the financial advisor in this financing round.

  • 6a211298352b5
    Cancel
    Date：2026-06
    /index.php?a=shows&catid=34&id=937

    XYZ Embodied AI, a leading Chinese embodied intelligence company, has raised several hundred million RMB in Series A financing, bringing its total funding to several hundred million RMB. The company is rapidly emerging as one of the fastest-growing player

  • 69d76acb23c14
    Cancel
    Date：2026-04
    /index.php?a=shows&catid=34&id=932

    Recently, AutoArk, a startup building a next-generation AIOS for hardware, has successfully closed two Pre-Series A funding rounds. The rounds were backed by Shokz, a world-renowned wearable device brand, alongside Guoruiyuan Private Equity Fund, Everpine

  • 69d4e0f6b6ec6
    Cancel
    Date：2026-03

    Chief Financial Advisor to NRT

  • 69c4d2e8c80fc
    Cancel
    Date：2026-03
    /index.php?a=shows&catid=34&id=927

    Recently, IRIS, a world-leading contact lens R&D and manufacturing platform, announced it has raised several hundred million RMB in Series B+ Financing. This round of financing was exclusively led by Cenova Capital, a well-known investment institution. C

  • 6969d6ff05a3c
    Cancel
    Date：2026-01
    /index.php?a=shows&catid=34&id=921

    Recently, CAStar Foods, a leader in China’s biosynthetic human-derived bioactive protein industry, announced the closing of a Series A+ financing round worth several hundred million RMB. The company’s independently developed A60 bioactive peptide replicates rare core protein fragments found in breast milk, boasting immense potential in the fields of nutritional immunology and health. Proceeds from this financing round will be mainly allocated to advancing the industrialization of the company’s core functional protein/peptide products and their global market expansion. CEC Capital acted as the exclusive financial advisor to CAStar Foods for this transaction.

  • 695a1e2987f75
    Cancel
    Date：2026-01
    /index.php?a=shows&catid=34&id=919

    Recently, MicroCyto announced the closing of a new round of equity financing worth nearly 300 million RMB. The investors include Beijing New Materials Industry Investment Fund, Beijing Medical and Health Industry Investment Fund, Zhongguancun Capital, and

  • 695ca7e89b238
    Cancel
    Date：2025-12
    /index.php?a=shows&catid=34&id=917

    Refine Biology recently announced the closing of a several hundred million RMB Series C financing round. The round was led by Xingxiang Asset Management Group, with participation from Royal Power XMXYG Fund as a co-investor. Proceeds from this financing w

  • 69002cbf83f23
    Cancel
    Date：2025-10

    Exclusive Financial Advisor


【网站地图】